SCHEMBL8846

SCHEMBL8846

CCCc1[nH]c(=O)oc1-c1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 6/20 0.46
PDE3A Q14432 6/20 0.46
GSK3B P49841 3/20 0.40
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
ITK Q08881 1/20 0.35
CDC7 O00311 1/20 0.35
HPGD P15428 2/20 0.35
TMIGD3 P0DMS9 1/20 0.35
ADORA1 P30542 1/20 0.35
PBRM1 Q86U86 1/20 0.34
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 2/20 0.33
ALDH1A1 P00352 2/20 0.33
RAB9A P51151 2/20 0.33
HSD17B10 Q99714 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7437589 0.89 PDE3B (0.39) PDE3BPDE3AGSK3BCDK5CDK5R1
SCHEMBL7272043 0.87 PDE3B (0.43) PDE3BPDE3AGSK3BCDC7HPGD
Fumaric Acid SCHEMBL9103152 0.80 PDE3B (0.40) PDE3BPDE3ACDK5CDK5R1ITK
SCHEMBL7270893 0.77 CYP1A2 (0.41) PDE3BPDE3AHPGDADORA1KDM4E
SCHEMBL7269315 0.75 PDE3B (0.49) PDE3BPDE3AGSK3BCDK5CDC7
SCHEMBL9360794 0.73 ELANE (0.40) KDM4CHPGDPBRM1ALDH1A1
SCHEMBL7415425 0.71 ELANE (0.44) HPGDPBRM1KDM4ENPC1ALDH1A1
SCHEMBL11225665 0.70 PDE3B (0.57) PDE3BPDE3AGSK3BCDK5CDK5R1
SCHEMBL10771601 0.70 PDE4A (0.53) PDE3BPDE3AKDM4EALDH1A1
SCHEMBL7278194 0.68 NOTUM (0.45) PDE3BPDE3AGSK3BCDC7NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2773 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230285556-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER OMEROS CORPORATION 2023-09-14 US claimed
WO-2023039578-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER OMEROS CORPORATION (US) 2023-03-16 WO claimed
US-8114152-B2 Stent coating ICON INTERVENTIONAL SYSTEMS, INC. (US) 2012-02-14 US claimed
US-20090062904-A1 STENT COATING ICON INTERVENTIONAL SYSTEMS, INC. 2009-03-05 US claimed
EP-1738759-A1 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same SuperGen, Inc. (US) 2007-01-03 EP claimed
US-20050118180-A1 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same SUPERGEN, INC. 2005-06-02 US claimed
EP-0783292-B1 INHIBITION OF HAIR GROWTH GILLETTE CO (US) 2003-11-19 EP claimed
EP-1276479-A2 INHIBITION OF ABNORMAL CELL PROLIFERATION WITH CAMPTOTHECIN AND COMBINATIONS INCLUDING THE SAME SuperGen, Inc. (US) 2003-01-22 EP claimed
US-20020111362-A1 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same SUPERGEN, INC. 2002-08-15 US claimed
WO-2001080843-A2 INHIBITION OF ABNORMAL CELL PROLIFERATION WITH CAMPTOTHECIN AND COMBINATIONS INCLUDING THE SAME SUPERGEN, INC. (US) 2001-11-01 WO claimed
EP-0539575-B1 INHIBITION OF METASTASIS IN PATIENTS HAVING CANCER WITH PYRIDYLOXAZOLE-2-ONES MERRELL PHARMA INC (US) 1997-07-23 EP claimed
EP-0783292-A1 INHIBITION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1997-07-16 EP claimed
US-5610171-A Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones MERRELL PHARMACEUTICALS INC. (US) 1997-03-11 US claimed
US-5554608-A INHIBITOR OF PROTEIN KINASE C GILLETTE COMPANY, THE, A DELAWARE CORPORATION 1996-09-10 US claimed
WO-1996009806-A2 INHIBITION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1996-04-04 WO claimed
WO-1993010778-A1 INHIBITION OF ANGIOGENESIS WITH PYRIDINYLOXAZOLE-2-ONES MERRELL DOW PHARMACEUTICALS INC. (US) 1993-06-10 WO claimed
EP-0539575-A1 INHIBITION OF METASTASIS IN PATIENTS HAVING CANCER WITH PYRIDYLOXAZOLE-2-ONES. MERRELL DOW PHARMA (US) 1993-05-05 EP claimed
WO-1992020337-A2 INHIBITION OF METASTASIS IN PATIENTS HAVING CANCER WITH PYRIDYLOXAZOLE-2-ONES MERRELL DOW PHARMACEUTICALS INC. (US) 1992-11-26 WO claimed
EP-0222358-B1 CARDIOTONIC HETEROCYCLIC OXAZOLONES MERRELL DOW PHARMACEUTICALS INC. (US) 1991-04-17 EP claimed
EP-0222358-A1 Cardiotonic heterocyclic oxazolones MERRELL DOW PHARMACEUTICALS INC. (US) 1987-05-20 EP claimed